跳至主要内容
临床试验/NCT03580447
NCT03580447已完成不适用

The Effect of Citrus Extract Administration on Markers of Oxidative Stress in Elderly Subjects

Maastricht University Medical Center2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2018年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
2
主要终点
Oxidative stress

研究概览

简要总结

This randomized, cross-over, double-blind, placebo-controlled trial aims to determine the effects of daily administration of citrus extract over a period of 4 weeks on markers of oxidative stress in elderly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
70 Years 至 85 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy individuals
  • Age 70-85 years
  • BMI < 30 kg/m2

排除标准

  • History or actual status of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological diseases, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol.
  • Disease with a life expectancy shorter than 5 years
  • Institutionalized (e.g. hospital or nursing home).
  • Subjects with abnormalities in haematology which may interfere with the endpoints of the study (to be decided by the principle investigator)
  • Use of drugs or hormones within 3 months prior to the start of the study which may interfere with the endpoints of the study (to be decided by the principle investigator)
  • Self-admitted Inflammation, (viral) infection (e.g. HIV or hepatitis B)
  • Subjects with an autoimmune disease (e.g. Rheumatoid arthritis)
  • Subjects with intestinal disorders which may interfere with the endpoints of the study (to be decided by the principle investigator)
  • Use of immunosuppressive drugs within 3 months prior to the start of the study
  • Use of medication (e.g. NSAIDs), antibiotics or corticosteroids which may interfere with the endpoints of the study (to be decided by the principle investigator)
  • Changes in medication that may significantly affect the study outcome (according to the investigator's judgment) within 1 month prior to the start of the study.
  • Use of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator) in the 180 days before the study
  • Use of (dietary) supplements containing antioxidants, vitamins and minerals
  • Weight gain or loss (> 3 kg in the previous 3 months)
  • Excessive intake of foods with a high polyphenol concentration
  • Use of pre-, pro or synbiotics within 1 month prior to the start of the study
  • Blood donation within 1 month prior to the start of the study
  • Excessive alcohol consumption (>20 alcoholic consumptions per week)
  • History of any side effects towards the intake of flavonoids or citrus fruits

结局指标

主要结局

Oxidative stress

时间窗: Change from baseline to four weeks supplementation, of each intervention period

Oxidative stress, as measured by blood biomarkers

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yala Stevens

MSc.

Maastricht University Medical Center

研究点 (2)

Loading locations...

相似试验